White Paper Reports the Five Essentials for Minimizing Clinical Development Risk

HD explains how a systematic risk mitigation system can prevent undue FDA rejection

“If a drug works, there should be no reason for a clinical trial to fail,” reports our latest white paper. This may seem like common sense, but many potentially valid drugs are denied FDA approval because of flawed clinical data that undermines the validity of overall efficacy and safety findings.

Titled What You Don’t Know Can Hurt You: Five Essentials for Minimizing Clinical Development Risk and Ensuring Your Greatest Chance of Success, the report shows how untreated quality issues at even a single investigator site can negatively impact the results of an entire study. It identifies the elements that every trial should deem mandatory in order to avoid such unnecessary failures.  

What you Don’t Know Can Hurt You includes topics such as:

• Why risk is at an all-time high in clinical development & the factors that make some trials more risk-prone than others
• How to employ systematic risk mitigation for any trial, including the five essentials and why they’re so vital
• Risk management tips for global and complex trials
• The type of information you should be collecting beyond patient data, how to capture it, and what to do with it

For more information, contact Kate Hendrick, Marketing Specialist, by email at khendrick@HealthDec.com or by phone at +1.919.967.1111 x116.